MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-11-07
DOI
10.3389/fonc.2019.01170
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-coding RNAs as potential therapeutic targets in breast cancer
- (2019) Deepti Tomar et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- NEAT1/miR‑124/STAT3 feedback loop promotes breast cancer progression
- (2019) Yamei Pang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A Comprehensive cis -eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies
- (2018) Xingyi Guo et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Microcalcifications in breast cancer: From pathophysiology to diagnosis and prognosis
- (2018) S. O'Grady et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling
- (2018) Zhiliang Lu et al. CANCER LETTERS
- Expression of long non-coding RNA YIYA promotes glycolysis in breast cancer
- (2018) Zhen Xing et al. CANCER RESEARCH
- Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5
- (2018) Yongchang Wei et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges
- (2018) Ramesh Butti et al. Molecular Cancer
- Long Noncoding RNA in Cancer: Wiring Signaling Circuitry
- (2018) Chunru Lin et al. TRENDS IN CELL BIOLOGY
- Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer
- (2018) Guohong Liu et al. Frontiers in Pharmacology
- Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case–control study
- (2018) Xuehong Zhang et al. PLOS MEDICINE
- Jab1/Cops5 contributes to chemoresistance in breast cancer by regulating Rad51
- (2018) Guohong Liu et al. CELLULAR SIGNALLING
- CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1
- (2018) Longxi Mao et al. EXPERIMENTAL CELL RESEARCH
- The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer
- (2018) Zhen Guo et al. GENE
- MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction
- (2017) Farah J Nassar et al. PHARMACOLOGY & THERAPEUTICS
- Prognostic and predictive biomarkers in breast cancer: Past, present and future
- (2017) Andrea Nicolini et al. SEMINARS IN CANCER BIOLOGY
- Complementary and Alternative Medicines and Patients With Breast Cancer: A Case of Mortality and Systematic Review of Patterns of Use in Patients With Breast Cancer
- (2017) Grayson A. Roumeliotis et al. Plastic Surgery
- Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
- (2016) Maya Ghoussaini et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives
- (2016) R. Costa et al. ANNALS OF ONCOLOGY
- An overview of the effective combination therapies for the treatment of breast cancer
- (2016) Cristina Núñez et al. BIOMATERIALS
- Treatment strategies for advanced hormone receptor-positive and human epidermal growth factor 2-negative breast cancer: the role of treatment order
- (2016) Edith A. Perez DRUG RESISTANCE UPDATES
- Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis
- (2016) Hui Guo et al. HEPATOLOGY
- Long noncoding RNAs in cancer: mechanisms of action and technological advancements
- (2016) Nenad Bartonicek et al. Molecular Cancer
- Breast cancer classification: linking molecular mechanisms to disease prognosis
- (2014) A. Taherian-Fard et al. BRIEFINGS IN BIOINFORMATICS
- Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer
- (2014) Yunbao Pan et al. CANCER BIOLOGY & THERAPY
- Breast Cancer: Epidemiology and Etiology
- (2014) ZiQi Tao et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- The Role of Long Noncoding RNAs in the Epigenetic Control of Gene Expression
- (2014) Mariangela Morlando et al. ChemMedChem
- A four-long non-coding RNA signature in predicting breast cancer survival
- (2014) Jin Meng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- lincRNAs: Genomics, Evolution, and Mechanisms
- (2013) Igor Ulitsky et al. CELL
- Long non-coding RNA: a new player in cancer
- (2013) Hua Zhang et al. Journal of Hematology & Oncology
- Genome Regulation by Long Noncoding RNAs
- (2012) John L. Rinn et al. Annual Review of Biochemistry
- Molecular Mechanisms of Long Noncoding RNAs
- (2011) Kevin C. Wang et al. MOLECULAR CELL
- Long noncoding RNAs and human disease
- (2011) Orly Wapinski et al. TRENDS IN CELL BIOLOGY
- Genetic variants in the MRPS30 region and postmenopausal breast cancer risk
- (2011) Ying Huang et al. Genome Medicine
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
- (2010) Rajnish A. Gupta et al. NATURE
- Long non-coding RNAs: insights into functions
- (2009) Tim R. Mercer et al. NATURE REVIEWS GENETICS
- Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer
- (2008) Simon N Stacey et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now